Steward Partners Investment Advisory
KURA icon

Steward Partners Investment Advisory’s Kura Oncology KURA Stock Holding History

Steward Partners Investment Advisory’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.41K Hold
220
– – ﹤0.01% 4198
2026
Q1 		$1.79K Buy
+220
New +$1.89K ﹤0.01% 4087

Other funds holding KURA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BVF Inc
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Armistice Capital
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $241M AUM 112.74% 1-Year Est. Return

Steward Partners Investment Advisory's KURA Position: Q2 2026 in Review

Steward Partners Investment Advisory held its Kura Oncology (KURA) position steady in Q2 2026 at 220 shares worth $2.41K. The position accounts for ﹤0.01% of the portfolio, ranked #4198.

Steward Partners Investment Advisory first reported a position in KURA in Q1 2026 and has held it in 2 quarters since. 221 funds tracked by Wall St. Rank hold KURA as of Q2 2026.

  • Steward Partners Investment Advisory held 220 shares of Kura Oncology worth $2.41K as of Q2 2026.
  • Steward Partners Investment Advisory left its Kura Oncology share count unchanged in Q2 2026.
  • Kura Oncology made up ﹤0.01% of Steward Partners Investment Advisory's portfolio in Q2 2026, its #4198 holding.
  • Steward Partners Investment Advisory first reported a position in Kura Oncology in Q1 2026 and has held it in 2 quarters since.
  • 221 funds tracked by Wall St. Rank held Kura Oncology as of Q2 2026.

Based on Steward Partners Investment Advisory's 13F filing for Q2 2026, filed 13 Aug 2026.